BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18687402)

  • 1. Sporadic midbrain dopamine neuron abnormalities in laboratory mice.
    Prasad K; Richfield EK
    Neurobiol Dis; 2008 Nov; 32(2):262-72. PubMed ID: 18687402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine biosynthesis is selectively abolished in substantia nigra/ventral tegmental area but not in hypothalamic neurons in mice with targeted disruption of the Nurr1 gene.
    Castillo SO; Baffi JS; Palkovits M; Goldstein DS; Kopin IJ; Witta J; Magnuson MA; Nikodem VM
    Mol Cell Neurosci; 1998 May; 11(1-2):36-46. PubMed ID: 9608532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signalling through phospholipase C beta 4 is not essential for midbrain dopaminergic neuron survival.
    Smits SM; van der Nobelen S; Hornman KJ; von Oerthel L; Burbach JP; Smidt MP
    Neuroscience; 2005; 136(1):171-9. PubMed ID: 16198487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic toxicity associated with oral exposure to the herbicide atrazine in juvenile male C57BL/6 mice.
    Coban A; Filipov NM
    J Neurochem; 2007 Mar; 100(5):1177-87. PubMed ID: 17217422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcellular distribution and plasticity of neurokinin-1 receptors in the rat substantia nigra and ventral tegmental area.
    Lessard A; Pickel VM
    Neuroscience; 2005; 135(4):1309-23. PubMed ID: 16165296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced glutamatergic phenotype of mesencephalic dopamine neurons after neonatal 6-hydroxydopamine lesion.
    Dal Bo G; Bérubé-Carrière N; Mendez JA; Leo D; Riad M; Descarries L; Lévesque D; Trudeau LE
    Neuroscience; 2008 Sep; 156(1):59-70. PubMed ID: 18706980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D2 receptor binding, Drd2 expression and the number of dopamine neurons in the BXD recombinant inbred series: genetic relationships to alcohol and other drug associated phenotypes.
    Hitzemann R; Hitzemann B; Rivera S; Gatley J; Thanos P; Shou LL; Williams RW
    Alcohol Clin Exp Res; 2003 Jan; 27(1):1-11. PubMed ID: 12543998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurochemical characterization of the release and uptake of dopamine in ventral tegmental area and serotonin in substantia nigra of the mouse.
    John CE; Budygin EA; Mateo Y; Jones SR
    J Neurochem; 2006 Jan; 96(1):267-82. PubMed ID: 16300629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiological properties of zebra finch ventral tegmental area and substantia nigra pars compacta neurons.
    Gale SD; Perkel DJ
    J Neurophysiol; 2006 Nov; 96(5):2295-306. PubMed ID: 16870835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consequences of partial and severe dopaminergic lesion on basal ganglia oscillatory activity and akinesia.
    Tseng KY; Kargieman L; Gacio S; Riquelme LA; Murer MG
    Eur J Neurosci; 2005 Nov; 22(10):2579-86. PubMed ID: 16307600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Search for the presence of glucocorticoid receptors in dopaminergic neurons of rat ventral tegmental area and substantia nigra.
    Czyrak A; Chocyk A
    Pol J Pharmacol; 2001; 53(6):681-4. PubMed ID: 11985346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the properties of identified dopaminergic neurons in the mouse substantia nigra and ventral tegmental area.
    Krashia P; Martini A; Nobili A; Aversa D; D'Amelio M; Berretta N; Guatteo E; Mercuri NB
    Eur J Neurosci; 2017 Jan; 45(1):92-105. PubMed ID: 27519559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of GABAA receptor subunit variants in midbrain dopaminergic neurons.
    Okada H; Matsushita N; Kobayashi K; Kobayashi K
    J Neurochem; 2004 Apr; 89(1):7-14. PubMed ID: 15030384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does the cerebral cortex exacerbate dopaminergic cell death in the substantia nigra of 6OHDA-lesioned rats?
    Luquin N; Mitrofanis J
    Parkinsonism Relat Disord; 2008; 14(3):213-23. PubMed ID: 18029221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insomnia following hypocretin2-saporin lesions of the substantia nigra.
    Gerashchenko D; Blanco-Centurion CA; Miller JD; Shiromani PJ
    Neuroscience; 2006; 137(1):29-36. PubMed ID: 16289583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degeneration of mesencephalic dopaminergic neurons in klotho mouse related to vitamin D exposure.
    Kosakai A; Ito D; Nihei Y; Yamashita S; Okada Y; Takahashi K; Suzuki N
    Brain Res; 2011 Mar; 1382():109-17. PubMed ID: 21276773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GIRK2 expression in dopamine neurons of the substantia nigra and ventral tegmental area.
    Reyes S; Fu Y; Double K; Thompson L; Kirik D; Paxinos G; Halliday GM
    J Comp Neurol; 2012 Aug; 520(12):2591-607. PubMed ID: 22252428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organization of ventral tegmental area projections to the ventral tegmental area-nigral complex in the rat.
    Ferreira JG; Del-Fava F; Hasue RH; Shammah-Lagnado SJ
    Neuroscience; 2008 Apr; 153(1):196-213. PubMed ID: 18358616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further studies on the relationship between dopamine cell density and haloperidol-induced catalepsy.
    Hitzemann B; Dains K; Kanes S; Hitzemann R
    J Pharmacol Exp Ther; 1994 Nov; 271(2):969-76. PubMed ID: 7965819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predominant surface distribution of neurokinin-3 receptors in non-dopaminergic dendrites in the rat substantia nigra and ventral tegmental area.
    Lessard A; Grady EF; Bunnett NW; Pickel VM
    Neuroscience; 2007 Feb; 144(4):1393-408. PubMed ID: 17197098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.